Health organisations have highlighted that many individuals with lung cancer have reported noticeable changes in their facial ...

Utidelone is under clinical development by BioStar Pharmaceuticals and currently in Phase I for Non-Small Cell Lung Cancer.

Muzastotug is under clinical development by Adagene Suzhou and currently in Phase II for Hepatocellular Carcinoma.

Murine Kras-driven lung cancer models have confirmed the key requirements for RAF, PI3K and RAL-GEF in vivo. Co-opted pathways required by oncogenic KRAS in order to sustain lung tumorigenesis ...

The FDA approved several drugs in December for the treatment of diseases including pancreatic adenocarcinoma, lung cancer, ...

N-terminal kinases (JNKs) have been proposed as therapeutic targets in multiple pathologies, including cancer, inflammation ...

Lung cancers are commonly known to affect smokers and other forms of tobacco users. According to the latest research, lung ...

A young, fit, and non-smoker British man was wrongly diagnosed with anxiety and prescribed medicine, while he actually had ...